98%
921
2 minutes
20
Background: Posttraumatic seizures (PTSs) are a major source of disability after traumatic brain injury (TBI). The Brain Trauma Foundation Guidelines recommend prophylactic anti-epileptics (AEDs) for early PTS in severe TBI, but high-quality evidence is lacking in mild TBI.
Methods: To determine the benefit of administering prophylactic AEDs, we performed a prospective and multicenter study evaluating consecutive patients who presented to a Level 1 trauma center from January 2017 to December 2020. We included all patients with mild TBI defined as Glasgow Coma Scale (GCS) 13-15 and a positive head computed tomography (CT). Patients were excluded for previous seizure history, current AED use, or a neurosurgical procedure. Patients were given a prophylactic 7-day course of AEDs on a week-on versus week-off basis and followed with in-person clinic visits, in-hospital evaluation, or a validated phone questionnaire.
Results: Four hundred and ninety patients were enrolled, 349 (71.2%) had follow-up, and 139 (39.8%) were given prophylactic AEDs. There was no difference between seizure rates for the prophylactic AED group (0.7%) and those without (2.9%; = 0.25). Patients who had a PTS were on average older (81.4 years) than patients without a seizure (64.8 years; = 0.02). Seizure rate increased linearly by age groups: <60 years old (0%); 60-70 years old (1.7%); 70-80 years old (2.3%); and >80 years old (4.6%).
Conclusion: Prophylactic AEDs did not provide a benefit for PTS reduction in mild TBI patients with a positive CT head scan.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282794 | PMC |
http://dx.doi.org/10.25259/SNI_38_2022 | DOI Listing |
J Neurosurg Case Lessons
June 2025
Department of Neurosurgery, Roper Saint Francis Healthcare, Charleston, South Carolina.
Background: The management of nonmissile penetrating head injuries is not well established given the heterogeneity of injuries described. The authors describe the management of a patient who presented to their institution along with a review of the literature.
Observations: The glass shard was removed in the operating room with the ophthalmology team without complication.
Neurosurg Rev
April 2025
Neurosurgical Service, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Background: Seizures have been reported to arise after middle meningeal artery embolization (MMAE) for the treatment of chronic subdural hematomas (cSDH). However, the rates and factors influencing their development have been poorly established in the literature. Herein, we assess for risk factors for seizures post-MMAE.
View Article and Find Full Text PDFSci Rep
March 2025
Department of Hematology, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Jing'an District, Shanghai, China.
This study examined the prevalence, risk factors, and prognosis of epilepsy in patients with primary central nervous system lymphoma (PCNSL) and explored the necessity of prophylactic antiepileptic treatment in this population. In this retrospective, observational, single-center study, we analyzed clinical data from PCNSL patients who were diagnosed at our institution between January 2018 and April 2023. The cohort comprised 214 patients with PCNSL (with a median age of 62 years), of which 128 (47.
View Article and Find Full Text PDFChilds Nerv Syst
February 2025
Neurosurgery Department, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
Introduction: Intracranial infections due to sinusitis and otitis, although rare, can progress rapidly and result in significant morbidity, necessitating multifaceted management including extended antibiotic therapy and surgical intervention. Predominantly affecting infants and older children, these infections have seen a perceived increase in incidence following the coronavirus disease 2019 (COVID-19) pandemic.
Objectives: Our study aims to describe the clinical and epidemiological characteristics of intracranial infections secondary to sinusitis or otitis in the pediatric population and assess changes in incidence and clinical presentation post-pandemic.
Medicine (Baltimore)
July 2024
Pharmaceutical Services Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
The use of prophylactic antiepileptic drugs (AEDs) post-subarachnoid hemorrhage (SAH), particularly aneurysmal SAH, is controversial, with limited data available. This has led the new American Heart Association/American Stroke Association (AHA/ASA) guidelines to recommend against using AEDs. This study is aimed at determining whether the use of AEDs for primary prophylaxis is effective in reducing the incidence of seizures post-SAH.
View Article and Find Full Text PDF